OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2025.15162 OL-30-3-15162 Retraction [Retracted] MEG-3-mediated Wnt/β-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma CuiXiangyu SunDezhou ShenBin WangXin 092025 30062025 30 3 416 Copyright: © 2025 Cui et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 16: 2797–2804, 2018; DOI: 10.3892/ol.2018.9048

Following the publication of the above paper, a concerned reader drew to the Editor's attention that the immunofluorescence assay data shown in Fig. 6E and F had apparently already appeared in a figure in a paper published in the journal Oncotarget that was written by different authors at different research institutes. Upon performing an independent analysis of the data in the Editorial Office, it came to light that western blot data shown in Figs. 2E, 2F and 3E, and the migration and invasion assay data shown in Fig. 2A-D, were also strikingly similar to data that had already appeared in previously published papers in different journals written by different authors at different research institutes.

Given that the abovementioned data had already been published previously in a range of different journals, the Editor of Oncology Letters has decided that this article should be retracted from the Journal. After contacting the authors, they accepted the Editor's decision to retract this paper. The Editor apologizes to the readership for any inconvenience caused.